Genmab A/S (GNMSF) Short term Debt (2019 - 2026)

Genmab A's (GNMSF) quarterly Short term Debt came in at $273.0 million in Q4 2025, up 1850.0% on a QoQ basis from $14.0 million in Q1 2025.

Genmab A/S (GNMSF) Short term Debt (2019 - 2026) Analysis & Trends

Genmab A (GNMSF) has 3 years of Short term Debt data on file, last reported at $273.0 million in Q4 2025.

Quarterly Short term Debt changed N/A year-over-year to $273.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $273.0 million (changed N/A YoY) and the FY2025 annual result came in at $273.0 million, changed N/A from the prior year.
Short term Debt rose to $273.0 million in Q4 2025, from $14.0 million in the prior quarter.
In the past five years, Short term Debt ranged from a high of $273.0 million in Q4 2025 to a low of $14.0 million in Q1 2025.

Download Data